Organovo trading halted, news pending
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2025
0mins
Should l Buy ?
Source: Business Insider
Trading Halt: Organovo (ONVO) has had its trading halted due to pending news, indicating potential significant developments for the company.
Corporate Actions: The company announced a 1-for-12 reverse stock split and is set to be acquired by Eli Lilly, which will expand Eli Lilly's IBD pipeline with Organovo’s FXR program.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
